Effectiveness of BNT162b2 Vaccine against Omicron in Children 5 to 11 Years of Age | NEJM

Just published NEJM
During Omicron, the 2-shot mRNA vaccine effectiveness among >250,000 children age 5 to 11 years old.

Read more: https://www.nejm.org/doi/full/10.1056/NEJMoa2203209